|
|
|
|
| The peptide market is booming, driving manufacturers to enhance processes and capacity. What key changes are shaping peptide manufacturing? How can continuous manufacturing boost efficiency and meet demand? Don’t miss our inaugural Pharmaceutical Online Live digital event on January 22nd. Registration is free thanks to the support of Federal Equipment Company. |
|
|
|
|
|
|
| Leveraging ISA-95 In A Pharma 4.0 World | Article | By John Harrington, HighByte | Explore core elements of the ISA-95 specification and how life sciences manufacturers can apply them within an integration solution designed for industrial data modeling, delivery, and governance. |
|
|
| Accelerated Development Of OSD Formulation For IND Submission | White Paper | By Saujanya Gosangari, Alcami | This paper highlights how the roller compaction process not only enhances efficiency but also improves the scalability of solid oral dosage production, supporting rapid development for regulatory approval. |
|
|
|
|
|
|
|
|
|
|
By Peter H. Calcott, Ph.D., FRSC, president and CEO, Calcott Consulting LLC | FDA's CDER recently issued a draft guidance: Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics. This article provides a summary and analysis. The public comment period ends January 14, 2025. |
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|